Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12326 - 12350 of 12824 in total
SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors).
Investigational
Matched Description: … SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein ... With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors). …
GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).
Investigational
Matched Description: … GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal …
Efmitermant alfa, a locally-acting GDF/activin ligand trap, is under investigation in clinical trial NCT03124459 (Study of ACE-083 in Patients With Charcot-marie-tooth Disease).
Investigational
Matched Description: … NCT03124459 (Study of ACE-083 in Patients With Charcot-marie-tooth Disease). ... Efmitermant alfa, a locally-acting GDF/activin ligand trap, is under investigation in clinical trial …
Bleomycin A2 is under investigation in clinical trial NCT00026208 (Combination Chemotherapy Plus Low-dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma).
Investigational
Matched Description: … Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma). ... Bleomycin A2 is under investigation in clinical trial NCT00026208 (Combination Chemotherapy Plus Low-dose …
Synephrine, also referred to as, p-synephrine, is naturally occurring alkaloid. It is present in approved drug products as neo-synephrine, its m-substituted analog. p-synephrine and m-synephrine are known for their longer acting adrenergic effects compared to norepinephrine. The similarity of naming between m-synephrine and the unsubstituted form, synephrine, is a source...
Experimental
Matched Description: … It is present in approved drug products as neo-synephrine, its m-substituted analog. p-synephrine and ... While the compounds share some chemical and pharmacological similarities, they are in fact distinct chemical …
Davunetide has been used in trials studying the treatment of Progressive Nonfluent Aphasia, Progressive Supranuclear Palsy, Predicted Tauopathies, Including, Corticobasal Degeneration Syndrome, and Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17. Davunetide is the first drug to improve memory performance by impacting the mechanisms that lead to physical damage in...
Investigational
Matched Description: … Davunetide has been used in trials studying the treatment of Progressive Nonfluent Aphasia, Progressive ... the first drug to improve memory performance by impacting the mechanisms that lead to physical damage in
Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy.
Withdrawn
Matched Description: … Withdrawn from the Canadian, US, and UK markets in 1963 due to nephropathy. …
BMS-394136 has been used in trials studying the diagnostic of Heart Diseases.
Investigational
Matched Description: … BMS-394136 has been used in trials studying the diagnostic of Heart Diseases. …
OBP-801 has been used in trials studying the treatment of Solid Tumor.
Investigational
Matched Description: … OBP-801 has been used in trials studying the treatment of Solid Tumor. …
Abituzumab has been used in trials studying the treatment of Prostate Cancer Metastatic.
Investigational
Matched Description: … Abituzumab has been used in trials studying the treatment of Prostate Cancer Metastatic. …
Rimeporide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Description: … Rimeporide has been used in trials studying the treatment of Muscular Dystrophy, Duchenne. …
T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational
Matched Description: … T-62 has been used in trials studying the treatment of Postherpetic Neuralgia. …
Pivagabine has been used in trials studying the treatment of Stress and Anxiety.
Investigational
Matched Description: … Pivagabine has been used in trials studying the treatment of Stress and Anxiety. …
Leukotriene B4 has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Leukotriene B4 has been used in trials studying the treatment of HIV Infections. …
Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms.
Experimental
Matched Description: … Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms. …
Q-Derp1 is developed by Cytos Biotechnology as an immunodrug. It is an antigen for the prevention of various major chronic diseases. Derp1 is the dominant allergic protein found in dust mite feces.
Investigational
Matched Description: … Derp1 is the dominant allergic protein found in dust mite feces. …
Rocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer).
Investigational
Matched Description: … Rocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A …
Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
Investigational
Matched Description: … Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. ... Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast …
MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).
Investigational
Matched Description: … (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)). ... MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical …
Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers).
Investigational
Matched Description: … And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers). ... Adriforant is under investigation in clinical trial NCT00992342 (A Phase 1 Study To Evaluate The Safety …
Telisotuzumab vedotin is under investigation in clinical trial NCT02099058 (A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors.).
Investigational
Matched Description: … Telisotuzumab vedotin is under investigation in clinical trial NCT02099058 (A Study Evaluating the Safety ... , Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors. …
Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).
Investigational
Matched Description: … Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus). ... Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on …
Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
Investigational
Matched Description: … Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes ... MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic …
Reloxaliase is a crystalline formulation of oxalate decarboxylase derived from Bacillus Subtilis. Reloxaliase is under investigation in clinical trial NCT03456830 (Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria).
Investigational
Matched Description: … Reloxaliase is under investigation in clinical trial NCT03456830 (Evaluate ALLN-177 in Patients With …
Telazorlimab is under investigation in clinical trial NCT03568162 (Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis).
Investigational
Matched Description: … and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis). ... Telazorlimab is under investigation in clinical trial NCT03568162 (Phase 2b Study to Evaluate the Efficacy …
Displaying drugs 12326 - 12350 of 12824 in total